A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...
CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.“I'm here three years later because I did find out and because I did finally ...
Lung cancer remains the leading cause of cancer-related deaths in the United States, but new advances in early detection are ...
bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...
All study participants simultaneously underwent NGS using three sample types: (1) BWF, (2) plasma, and (3) tumor tissue collected during bronchoscopy. The full patient set (FPS) included all enrolled ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...